Industry News
News for Providers
Top stories summarized by our editors
8/7/2020

The Hawaii Coordinated Access Resource Entry System hotline has expanded its hours to provide 24/7 help with access substance use and mental health resources, along with crisis support. The hotline is a partnership between the Hawaii Health Department and the University of Hawaii at Manoa.

Full Story:
Honolulu Civil Beat
More Summaries:
University of Hawaii
8/7/2020

Perfluoroalkyl substances, or PFAS, could be linked to obesity, endometriosis, polycystic ovary syndrome and other adverse health outcomes, according to a series paper published in The Lancet Diabetes & Endocrinology. Additionally, the researchers wrote that PFAS, bisphenols and certain pesticides may damage semen, while flame retardants and chemicals found in some pesticides could contribute to IQ loss and attention deficit hyperactivity disorder.

8/7/2020

The J.D. Power 2020 U.S. Pharmacy Study shows consumers are embracing health care options offered by major drug store chains, and this is the result of a strategy by pharmacies to become the "center of gravity for consumer health care,"says James Beem, managing director of health care intelligence at J.D. Power. He adds that big drug store chains are moving to become health care hubs by occupying space that had been reserved for primary care physician offices.

Full Story:
HealthLeaders Media
8/7/2020

Health care leaders in western New York say the quick growth in telehealth usage has been a positive effect of the novel coronavirus pandemic. "A crisis like this has a way for driving two to three years of innovation in two or three months," said Dr. Robert Zielinski, associate medical director at Buffalo Medical Group.

More Summaries:
Buffalo Medical Group
8/7/2020

Pfizer will be producing Gilead Sciences' coronavirus-fighting drug remdesivir in a bid to turn out enough of the antiviral to treat more than 2 million patients by the end of the year. Pfizer signed a multi-year agreement for the capacity-boosting arrangement, joining a manufacturing network that Gilead says now includes more than 40 companies globally.

Full Story:
Reuters
8/7/2020

Research published in the journal Neurology found taking vitamin D and calcium supplements may reduce the rate of benign paroxysmal positional vertigo by 24%, when compared with not taking the supplements. The findings, based on more than 900 patients with BPPV, showed people who had low vitamin D levels at baseline saw the greatest benefit.

Full Story:
HealthDay News
More Summaries:
Vertigo
8/7/2020

American Indian and Alaska Native adults were more likely to be in fair or poor health, when compared with US adults overall, but no differences were seen among AIAN adults based on urbanization levels, according to data from the CDC's National Center for Health Statistics. AIAN adults living in rural areas, however, had the highest rates of diagnosed diabetes.

8/7/2020

Black youths with solid malignant cancers had lower odds of receiving proton radiotherapy, compared with white peers, even after accounting for enrolling institution location, distance to radiotherapy facility and metastatic disease, according to a study in JAMA Oncology. The findings suggest the higher adverse effect risk among Black children with solid cancer, and such racial disparity in proton treatment access may be addressed through equitable and fair therapy distribution, said researcher Dr. Danielle Bitterman.

8/7/2020

Mice with multiple myeloma that were given the novel Pb-212-anti-CD38 alpha-radioimmunotherapy had significant cell proliferation inhibition, which restricted tumor growth and improved survival, compared with controls, according to a study in the Journal of Nuclear Medicine. Researchers also said that Pb-212-anti-CD38's central production, extended half-life and global distribution indicate its clinical feasibility for treating multiple myeloma.

Full Story:
Axis Imaging News
8/7/2020

A study in the International Journal of Colorectal Disease found that patients who were treated with metformin had a significantly lower risk of developing colorectal cancer, compared with those who were not treated with metformin or sulfonamide monotherapy. The findings, based on a systematic review of 17 studies with a total of 1,092,074 diabetes patients, also found that the use of metformin was tied to a significantly lower CRC risk among American and European patients.

Full Story:
Medical Dialogues
More Summaries:
sulfonamide

Pages